RSS-Feed abonnieren
DOI: 10.1055/s-0043-1770337
Prenatal Ultrasound Findings of Circumvallate Placenta and Pregnancy Outcomes
Funding This research was made possible through internal funding.
Abstract
Objective Circumvallate placenta has a suggested association with adverse pregnancy outcomes (antenatal bleeding, placental abruption, preterm birth, emergency cesarean, small for gestational age infants, and stillbirth). The aim was to determine if prenatal diagnosis of circumvallate placenta is associated with these adverse pregnancy outcomes.
Study Design Pregnancies with a singleton gestation prenatally diagnosed with circumvallate placenta between January 1, 2012 and March 31, 2021 were identified. Adverse pregnancy outcomes were obtained. Rates of adverse pregnancy outcomes were compared among those with prenatally diagnosed circumvallate placentas to those without this prenatal diagnosis with a 4:1 control matched group. Pregnancies with known fetal anomalies or other placental abnormalities were excluded. Statistical analyses included Student's t-test and Χ 2 with p < 0.05 considered significant.
Results Prenatal ultrasound findings of circumvallate placenta were seen in 179 pregnant people (0.20% of all anatomic US studies and 0.17% of all deliveries). Diagnosis was made at a mean gestational age of 19.8 ± 2.4 weeks. Adverse pregnancy outcomes were similar between groups.
Conclusion Prenatal ultrasound findings of circumvallate placenta do not correlate with adverse pregnancy outcomes. Given overall good prognosis, prenatal diagnosis of circumvallate placenta may not warrant additional surveillance during pregnancy.
Key Points
-
The risk of prenatally diagnosed circumvallate placenta was previously unclear.
-
Prenatally diagnosed circumvallate placenta is not associated with adverse pregnancy outcomes.
-
No change in management may be necessary with prenatally diagnosed circumvallate placenta.
Keywords
circumvallate placenta - prenatal diagnosis - adverse pregnancy outcomes - antenatal bleedingPublikationsverlauf
Eingereicht: 05. Januar 2023
Angenommen: 19. Mai 2023
Artikel online veröffentlicht:
19. Juni 2023
© 2023. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Hunt AB, Mussey RD, Faber JE. Circumvallate placenta. New Orleans Med Surg J 1947; 100 (05) 203-207
- 2 Paalman RJ, Vander Veer CG, Rapids G. Circumvallate placenta. Am J Obstet Gynecol 1953; 65 (03) 491-497
- 3 Suzuki S. Clinical significance of pregnancies with circumvallate placenta. J Obstet Gynaecol Res 2008; 34 (01) 51-54
- 4 Taniguchi H, Aoki S, Sakamaki K. et al. Circumvallate placenta: associated clinical manifestations and complications-a retrospective study. Obstet Gynecol Int 2014; 2014: 986230
- 5 Rolschau J. Circumvallate placenta and intrauterine growth retardation. Acta Obstet Gynecol Scand 1978; 57 (Suppl. 72) 11-14
- 6 Cunningham FG, Leveno KJ, Bloom SL. et al. Placental abnormalities. In: Williams Obstetrics, 26e. McGraw-Hill Education; 2022
- 7 Suzuki S. Antenatal screening for circumvallate placenta. J Med Ultrason 2008; 35 (02) 71-73
- 8 Duryea EL, Hawkins JS, McIntire DD, Casey BM, Leveno KJ. A revised birth weight reference for the United States. Obstet Gynecol 2014; 124 (01) 16-22